Saturday, 14 November 2026European Markets

HEIJMANS, EIFFAGE, Another 1 Companies Have A High Dividend Yield And Return On Equity In The Engineering & Construction Industry.

Automated market report from our archive (2020–2024), published before source-traceability. How we work

Loading stream...

(vianews) - heijmans (heijm.as) is among this list of stock assets with the highest dividend rate and return on equity on the engineering & construction industry.

financial asset price forward dividend yield return on equity
heijmans (heijm.as) €11.44 7.24% 20.53%
eiffage (fgr.pa) €104.25 3.43% 19.06%
arcadis (arcad.as) €37.40 1.95% 13.1%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. heijmans (heijm.as)

7.24% forward dividend yield and 20.53% return on equity

heijmans n.v. engages in the property development, construction and technical services, and infrastructure businesses in the netherlands and internationally. the company focuses on the development of large and smaller-scale projects in urban and out-of-town areas, as well as acts as an initiator, developer, and seller of residential properties. it also engages in building homes; and the restoration, redevelopment, renovation, maintenance, and service of existing housing stock. in addition, the company designs, realizes, and maintains electro-technical and mechanical installations; and realizes large-scale and complex construction contracts in the customer and market segments of health care, government and semi-government organizations, commercial property, the high-tech clean industry, and datacenters, as well as provides management and maintenance services. further, it focuses on the construction, enhancement, and maintenance of road infrastructure and public spaces, including related installations and on-site objects. the company was founded in 1923 and is headquartered in rosmalen, the netherlands.

earnings per share

as for profitability, heijmans has a trailing twelve months eps of €3.16.

pe ratio

heijmans has a trailing twelve months price to earnings ratio of 3.62. meaning, the purchaser of the share is investing €3.62 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 20.53%.

volatility

heijmans's last week, last month's, and last quarter's current intraday variation average was a positive 0.76%, a negative 0.38%, and a positive 1.45%.

heijmans's highest amplitude of average volatility was 1.45% (last week), 1.90% (last month), and 1.45% (last quarter).

moving average

heijmans's worth is above its 50-day moving average of €11.14 and above its 200-day moving average of €10.73.

yearly top and bottom value

heijmans's stock is valued at €11.44 at 17:40 est, way under its 52-week high of €15.90 and way above its 52-week low of €8.96.

more news about heijmans.

2. eiffage (fgr.pa)

3.43% forward dividend yield and 19.06% return on equity

eiffage sa engages in the construction, property development, urban development, civil engineering, metallic construction, roads, energy systems, and concessions businesses in france and internationally. the company construction segment offers urban development, building design and construction, property development, and maintenance and services works. its infrastructure segment is involved in undertaking civil engineering, road and rail design and construction, drainage, earthworks, and metallic construction. the company's energy systems segment designs, constructs, integrates, operates, and maintains energy and telecommunication systems and equipment. its concessions segment constructs and manages concession contracts and public-private partnerships. the company was incorporated in 1920 and is headquartered in vélizy-villacoublay, france.

earnings per share

as for profitability, eiffage has a trailing twelve months eps of €9.36.

pe ratio

eiffage has a trailing twelve months price to earnings ratio of 11.14. meaning, the purchaser of the share is investing €11.14 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 19.06%.

yearly top and bottom value

eiffage's stock is valued at €104.25 at 17:40 est, under its 52-week high of €106.00 and way above its 52-week low of €79.80.

revenue growth

year-on-year quarterly revenue growth grew by 7.9%, now sitting on 20.87b for the twelve trailing months.

moving average

eiffage's value is above its 50-day moving average of €102.22 and way above its 200-day moving average of €93.86.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, eiffage's stock is considered to be oversold (<=20).

more news about eiffage.

3. arcadis (arcad.as)

1.95% forward dividend yield and 13.1% return on equity

arcadis nv operates as a design and consultancy firm for natural and built assets worldwide. the company operates through four segments: europe & middle east, the americas, asia pacific, and callisonrtkl. it offers architectural based design consultancy services; and asset management services, such as asset management strategy and planning, asset management decision making and operational optimization, life cycle planning and asset management systems, asset information/condition assessment, risk and review, organization and people, and asset management/o&m. the company also provides business advisory services, including asset strategy and performance, business transformation and resiliency, investment and finance, operations and maintenance, and technology and information; cost and commercial management services; and design and engineering solutions for highways, railways, bridges, tunnels, power utilities, water utilities, ports and waterways, geotechnics, architecture, and structures, as well as building mechanical, electrical, and plumbing. in addition, it offers digital environmental health safety and sustainability, environmental restoration, and project management solutions. further, the company provides mobility solutions for connected highways, intelligent rail and transit, integrated airports, and new mobility; places solutions; resilience solutions, including climate adaption, energy transition, enviro socio permitting, environmental restoration, sustainable advisory, sustainable operations, and water optimization; and water supply and treatment, distribution, resource management, and industrial water and wastewater services. it serves industrial manufacturing, technology, property and investment, contractors, and energy and resources sectors. the company was formerly known as heidemij nv and changed its name to arcadis n.v. in october 1997. arcadis nv was founded in 1888 and is headquartered in amsterdam, the netherlands.

earnings per share

as for profitability, arcadis has a trailing twelve months eps of €1.53.

pe ratio

arcadis has a trailing twelve months price to earnings ratio of 24.44. meaning, the purchaser of the share is investing €24.44 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.1%.

volatility

arcadis's last week, last month's, and last quarter's current intraday variation average was 0.78%, 0.08%, and 1.14%.

arcadis's highest amplitude of average volatility was 0.78% (last week), 1.33% (last month), and 1.14% (last quarter).

more news about arcadis.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,577 source documents archived
Query this data → isubstrate.com